WO2007034278A3 - Antagonistes du recepteur du c3a - Google Patents
Antagonistes du recepteur du c3a Download PDFInfo
- Publication number
- WO2007034278A3 WO2007034278A3 PCT/IB2006/002561 IB2006002561W WO2007034278A3 WO 2007034278 A3 WO2007034278 A3 WO 2007034278A3 IB 2006002561 W IB2006002561 W IB 2006002561W WO 2007034278 A3 WO2007034278 A3 WO 2007034278A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- receptor antagonists
- imidazole derivatives
- fused imidazole
- treating
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
L'invention porte sur des composés imidazo[4,5-c] pyridine à substitution aryle. Ces composés sont utiles dans des compositions pharmaceutiques comme antagonistes du C3a pour traiter différentes affections médicales associées à la cascade du complément. L'invention porte également sur des méthodes de traitement correspondantes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71845105P | 2005-09-19 | 2005-09-19 | |
US60/718,451 | 2005-09-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007034278A2 WO2007034278A2 (fr) | 2007-03-29 |
WO2007034278A3 true WO2007034278A3 (fr) | 2007-05-18 |
Family
ID=37779396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/002561 WO2007034278A2 (fr) | 2005-09-19 | 2006-09-18 | Antagonistes du recepteur du c3a |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007034278A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4738419B2 (ja) * | 2005-11-30 | 2011-08-03 | 富士フイルムRiファーマ株式会社 | アミロイドの凝集及び/又は沈着に起因する疾患の診断薬及び治療薬 |
CN101594909A (zh) * | 2006-09-07 | 2009-12-02 | 比奥根艾迪克Ma公司 | 用于治疗炎性病症、细胞增殖性失调、免疫失调的irak调节剂 |
US7868001B2 (en) * | 2007-11-02 | 2011-01-11 | Hutchison Medipharma Enterprises Limited | Cytokine inhibitors |
EP2184273A1 (fr) | 2008-11-05 | 2010-05-12 | Bayer CropScience AG | Composés substitués par l'halogène comme pesticides |
PL2547678T3 (pl) * | 2010-03-18 | 2016-10-31 | Związki przeciwzapalne | |
WO2011137587A1 (fr) * | 2010-05-06 | 2011-11-10 | Hutchison Medipharma Limited | Inhibiteurs de cytokines |
JP6618682B2 (ja) | 2011-06-22 | 2019-12-11 | アペリス・ファーマシューティカルズ・インコーポレイテッドApellis Pharmaceuticals,Inc. | 補体阻害剤による慢性障害の治療方法 |
WO2014172190A1 (fr) | 2013-04-15 | 2014-10-23 | E. I. Du Pont De Nemours And Company | Amides fongicides |
AU2016269839B2 (en) | 2015-06-03 | 2021-07-08 | The University Of Queensland | Mobilizing agents and uses therefor |
CN115745848A (zh) * | 2022-12-07 | 2023-03-07 | 上海优合生物科技有限公司 | 一种氨基胍的加工合成工艺 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030778A1 (fr) * | 1999-10-27 | 2001-05-03 | Novartis Ag | Composes thiazole et imidazo [4,5-b] pyridine et leur utilisation pharmaceutique |
EP1104762A1 (fr) * | 1998-08-03 | 2001-06-06 | Laboratorios S.A.L.V.A.T., S.A. | Imidazo 1,2a]azines substituees servant d'inhibiteurs selectifs de la cox-2 |
WO2001057038A1 (fr) * | 2000-02-01 | 2001-08-09 | Basf Aktiengesellschaft | Composes heterocycliques et leur utilisation comme inhibiteurs de parp |
WO2003051890A1 (fr) * | 2001-12-14 | 2003-06-26 | Aegera Therapeutics Inc. | Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides |
WO2004111061A1 (fr) * | 2003-06-13 | 2004-12-23 | Aegera Therapeutics Inc. | Imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides acyles et non acyles, et utilisations associees |
WO2004111060A1 (fr) * | 2003-06-13 | 2004-12-23 | Aegera Therapeutics Inc. | Imidazo[2,1-b]-1,3,4-thiadiazole sulfoxydes et sulfones |
-
2006
- 2006-09-18 WO PCT/IB2006/002561 patent/WO2007034278A2/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1104762A1 (fr) * | 1998-08-03 | 2001-06-06 | Laboratorios S.A.L.V.A.T., S.A. | Imidazo 1,2a]azines substituees servant d'inhibiteurs selectifs de la cox-2 |
WO2001030778A1 (fr) * | 1999-10-27 | 2001-05-03 | Novartis Ag | Composes thiazole et imidazo [4,5-b] pyridine et leur utilisation pharmaceutique |
WO2001057038A1 (fr) * | 2000-02-01 | 2001-08-09 | Basf Aktiengesellschaft | Composes heterocycliques et leur utilisation comme inhibiteurs de parp |
WO2003051890A1 (fr) * | 2001-12-14 | 2003-06-26 | Aegera Therapeutics Inc. | Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides |
WO2004111061A1 (fr) * | 2003-06-13 | 2004-12-23 | Aegera Therapeutics Inc. | Imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides acyles et non acyles, et utilisations associees |
WO2004111060A1 (fr) * | 2003-06-13 | 2004-12-23 | Aegera Therapeutics Inc. | Imidazo[2,1-b]-1,3,4-thiadiazole sulfoxydes et sulfones |
Also Published As
Publication number | Publication date |
---|---|
WO2007034278A2 (fr) | 2007-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007034282A3 (fr) | Composes de biphenylimidazole utilises comme antagonistes du recepteur du c3a | |
WO2007034278A3 (fr) | Antagonistes du recepteur du c3a | |
IL185611A0 (en) | Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same | |
EA201000615A1 (ru) | Производные имидазо[1,2-а]пиридина, применимые в качестве ингибиторов апк (активиноподобной киназы) | |
IL204693A0 (en) | Imidazo[1, 2 - a] pyrimidine derivatives for the treatment of diseases such as diabetes | |
WO2007027734A3 (fr) | Heterocycles d'azote pontes et bicycliques | |
WO2007028135A3 (fr) | Composes a base d'imidazopyridine | |
WO2006126081A3 (fr) | Pyridine [2,3-b] pyrazinones | |
ZA201000212B (en) | Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treatment of inflammation | |
MX2009004715A (es) | Compuestos heterociclicos como agentes antiinflamatorios. | |
WO2007106469A3 (fr) | Derives bicycliques de l'acide carboxylique utiles dans le traitement de troubles metaboliques | |
WO2008032157A3 (fr) | Synthèse de 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones | |
WO2007044885A3 (fr) | Derives de piperidine et leurs procedes d'utilisation | |
WO2007000339A8 (fr) | Derives bicycliques en tant qu’inhibiteurs de kinase p38 | |
WO2006104826A3 (fr) | Composes antagonistes du recepteur du glucagon, compositions renfermant de tels composes et methodes d'utilisation | |
WO2006126082A3 (fr) | Pyridine [3,4-b] pyrazinones | |
WO2006067614A3 (fr) | Derives heteroaromatiques utiles en tant qu'agents anticancereux | |
UA99619C2 (en) | 3-(imidazolyl)-pyrazolo[3,4-b]pyridines | |
GEP20135780B (en) | Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents | |
EP1814885A4 (fr) | Nouveaux composes bicycliques heterocycliques, leur procede de preparation et compositions les contenant | |
NZ552137A (en) | New 4-benzylidene-piperidin derivatives | |
WO2008048867A3 (fr) | Composés hétoroaromatiques bicycliques | |
WO2008077557A8 (fr) | Dérivés 8-éthynylxanthine en tant qu'antagonistes sélectifs du récepteur 2a | |
MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
WO2007065684A3 (fr) | Composes organiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06808851 Country of ref document: EP Kind code of ref document: A2 |